Overview: Fasting Insulin TestIntroduction: The Fasting Insulin Test measures fasting insulin levels to diagnose diabetes or insulin resistance, causing fatigue or weight gain. Following 2023 ADA guidelines, it uses immunoassay for high specificity, supporting diabetes screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected type 2 diabetes or insulin resistance.
Other Names: Insulin Fasting Assay, Diabetes Insulin Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Fasting insulin testing began in the 1970s with diabetes research. Immunoassay-based methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures fasting insulin to diagnose diabetes or insulin resistance, guides treatment, and evaluates patients with fatigue or weight gain.
Test Parameters: 1. Fasting Insulin
Pretest Condition: Fasting 10-12 hours required. Collect serum or plasma. Report history of fatigue, weight gain, or diabetes symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, weight gain, high blood sugar, or family history of diabetes. Include current medications, especially metformin.
Consent: Written consent required, detailing the tests purpose, diabetes implications, and risks of blood collection.
Procedural Considerations: Uses immunoassay to measure fasting insulin in serum or plasma. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for diabetes diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Non-fasting samples may reduce accuracy.
Clinical Significance: Elevated fasting insulin suggests insulin resistance or type 2 diabetes, guiding lifestyle changes or medication. Normal levels may require further testing.
Specialist Consultation: Consult an endocrinologist or primary care physician for result interpretation and treatment planning.
Additional Supporting Tests: HbA1c, glucose tolerance test, or C-peptide to confirm diabetes or insulin resistance.
Test Limitations: Not specific to one condition; insulin levels vary with metabolic states. Clinical correlation is needed.
References: ADA Diabetes Guidelines, 2023; Diabetes Care, DeFronzo RA, 2022.
